Dual transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in SOD1 transgenic rats

Leyan Xu, Peilin Shen, Thomas Hazel, Karl Johe, Vassilis E. Koliatsos

Research output: Contribution to journalArticle

Abstract

Stem cells provide novel sources of cell therapies for motor neuron disease that have recently entered clinical trials. In the present study, we transplanted human neural stem cells (NSCs) into the ventral horn of both the lumbar (L4-L5) and cervical (C4-C5) protuberance of SOD1 G93A rats, in an effort to test the feasibility and general efficacy of a dual grafting paradigm addressing several muscle groups in the front limbs, hind limbs and the respiratory apparatus. Transplantation was done prior to the onset of motor neuron disease. Compared with animals that had received dead NSC grafts (serving as controls), rats with live NSCs grafted at the two spinal levels lived 17 days longer. Disease onset in dually grafted animals was delayed by 10 days compared to control animals. Disease duration in NSC-grafted animals was longer by 7 days compared to controls. Our results support the potential of NSC grafts at multiple levels of spinal cord as future cellular therapy for motor neuron disease.

Original languageEnglish (US)
Pages (from-to)222-226
Number of pages5
JournalNeuroscience Letters
Volume494
Issue number3
DOIs
StatePublished - May 2 2011

Keywords

  • Amyotrophic lateral sclerosis
  • Animal models
  • Cell therapies
  • Grafting
  • Regeneration

ASJC Scopus subject areas

  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Dual transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in SOD1 transgenic rats'. Together they form a unique fingerprint.

  • Cite this